Clinical Trial Update: A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 prospective trial comparing ranibizumab plus dexamethasone versus ranibizumab monotherapy for wet age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Wet Age-related Macular Degeneration

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lucentis (ranibizumab)

Snippet

Sponsor: Subhransu K. Ray, M.D., Ph.D. | Conditions: Exudative Age-Related Macular Degeneration | Phase 1, Phase 2 | Status: COMPLETED